| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/27/2006 | WO2006044754A2 Process for preparing telmisartan |
| 04/27/2006 | WO2006044732A2 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 04/27/2006 | WO2006044528A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044457A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/27/2006 | WO2006044454A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | WO2006044355A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 04/27/2006 | WO2006043839A1 Nitrobenzindoles and their use in cancer therapy |
| 04/27/2006 | WO2006043515A1 Pyrimidine-5-carboxylic acid derivative |
| 04/27/2006 | WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring |
| 04/27/2006 | WO2006014290A3 Anti-inflammatory medicaments |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089371 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 04/27/2006 | US20060089369 pyrimidine and pyridine derivatives; diabetes, neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency, cancer |
| 04/27/2006 | US20060089367 New indole or benzimidazole derivatives as CB1 inverse agonists |
| 04/27/2006 | US20060089365 Heterocyclic compounds useful as nurr-1 activators |
| 04/27/2006 | US20060089364 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents |
| 04/27/2006 | US20060089363 Antibacterial agents |
| 04/27/2006 | US20060089361 Methods for treating retinal diseases |
| 04/27/2006 | US20060089360 Inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis; 6-(1H-indol-5-yl)-N-(4-(trifluoromethyl)phenyl)-4-pyrimidinamine |
| 04/27/2006 | US20060089359 For prophylaxis and therapy of cancer |
| 04/27/2006 | US20060089356 Substituted imidazoles as cannabinoid receptor modulators |
| 04/27/2006 | US20060089348 neurokinin-2 and neurokinin-3 antagonists; schizophrenia, COPD, asthma, irritable bowel syndrome; N'-ethyl-3-methyloxy-N',2-diphenyl-4-quinolinecarbohydrazide |
| 04/27/2006 | US20060089347 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics |
| 04/27/2006 | US20060089262 Substituted (thioxo)carbonylamino phenyl uraciles |
| 04/27/2006 | US20060088816 Detection of transmembrane potentials using N,N,N'-Trialkyl thiobarbituric acid-derived polymethine oxonols |
| 04/27/2006 | DE102004051277A1 Heterocyclische Carbonylverbindungen Heterocyclic carbonyl |
| 04/27/2006 | CA2584702A1 Nitrobenzindoles and their use in cancer therapy |
| 04/27/2006 | CA2584422A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2584317A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2583158A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 04/27/2006 | CA2580913A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/26/2006 | EP1650205A1 Cyclohexanecarboxylic acid compound |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1648898A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/26/2006 | EP1648885A1 Novel compounds |
| 04/26/2006 | EP1648884A2 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 04/26/2006 | EP1648875A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 04/26/2006 | EP1648448A1 Chemical compounds |
| 04/26/2006 | EP1648447A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 04/26/2006 | EP1648426A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | CN1764668A Phosphonooxy quinazoline derivatives and their pharmaceutical use |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764650A 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 04/26/2006 | CN1764648A hydroxamid acid derivatives as histone deacetylase (HDAC) inhibitors |
| 04/26/2006 | CN1764453A Therapeutic formulation for mainly of diarrhea large intesitine irritation syndrome |
| 04/26/2006 | CN1763038A Novel benzisotriazole organic compound and preparation method and uses |
| 04/26/2006 | CN1763037A Novel triazole organic compound and preparation method and uses |
| 04/26/2006 | CN1763036A Novel potassium losartan crystal form |
| 04/26/2006 | CN1253451C Novel indodyl oxazole compound and its preparation and application |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/25/2006 | US7034069 High molecular weight hydroxyphenylbenzotriazole uv-absorbers for thin film applications |
| 04/25/2006 | US7034051 Fused bicyclic carboxamide derivatives and methods of their use |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034048 Gastrin and cholecystokinin receptor ligands (III) |
| 04/25/2006 | US7034047 Triazole derivative |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034030 Pyralopyridines, process for their preparation and use as therapeutic compounds |
| 04/25/2006 | US7034029 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7034019 Prodrugs of HIV replication inhibiting pyrimidines |
| 04/20/2006 | WO2006041636A2 Amino substituted aryloxybenzylpiperidine derivatives |
| 04/20/2006 | WO2006041405A1 Substituted amino-pyrimidones and uses thereof |
| 04/20/2006 | WO2006040666A1 Substituted n-alkylpyrimidinones |
| 04/20/2006 | WO2006040646A1 Benzimidazole or indole amides as inhibitors of pin1 |
| 04/20/2006 | WO2006040625A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 04/20/2006 | WO2006040568A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | WO2006040528A1 Phenoxy benzamide compounds with utility in the treatment of type 2 diabetes and obesity |
| 04/20/2006 | WO2006040526A1 Quinazoline derivatives for use against cancer |
| 04/20/2006 | WO2006040192A1 Pyrrolidine derivatives as histamine receptors ligands |
| 04/20/2006 | WO2006040182A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040176A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040056A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 04/20/2006 | WO2006039977A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators |
| 04/20/2006 | WO2006023562A3 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase |
| 04/20/2006 | WO2006021002A3 Compounds useful for inhibiting chk1 |
| 04/20/2006 | WO2005115398A3 Hiv integrase inhibitors |
| 04/20/2006 | WO2005033098A8 Salts and polymorphs of a pyrrole-substituted indolinone compound |
| 04/20/2006 | US20060084811 Method for the synthesis of a benzimidazole compound |
| 04/20/2006 | US20060084802 Modulate function of peroxisome proliferator-activated receptors (PPAR) gamma or PPAR delta; diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis; 2-Amino-5-bromo-isonicotinic acid methyl and ethyl esters; 2-amino-5-iodo-isonicotinic acid pentyl ester |
| 04/20/2006 | US20060084687 N-(3-aminopropyl)-N-[(1R)-1-(1-benzyl-1H-benzimidazol-2-yl)-2-methylpropyl]-4-chlorobenzamide;kinesin spindle protein modulators; anticarcinogenic agents; in vivo stability, bio-availability; diagnosis/medical/;antitumor agents hyperplasia; restinosis; antiinflammatory agents; cardiac hypertrophy |
| 04/20/2006 | US20060084681 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/20/2006 | US20060084651 Chemical compounds |
| 04/20/2006 | US20060084648 Ethynyl derivatives as factor xa inhibitors |
| 04/20/2006 | US20060084645 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 04/20/2006 | US20060084644 Atherosclerosis, unwanted cellular growth or cellular proliferation, diabetes, inflammatory conditions and vascular occlusive pathologic conditions; novel compound 1-[4-(4-Hydroxy-6'-phenyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-ylamino)-phenyl]-ethanone; modulation of glycosidase enzymes |
| 04/20/2006 | US20060084643 6-Fluoro-10-[3-(2-methoxy-ethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene; dopamine D2 and serotonin receptor anatagonist; neuroleptic agent, antidepressnt; psychological, bipolar disorders, psychosis, schizophrenia, acute mania |
| 04/20/2006 | US20060084640 Vanilloid receptor ligands and their use in treatments |